Consistent with the findings in the livers of mice with NASH, the mRNA level of Chchd2 in hepatocytes was not changed by palmitate or LPS treatment (Supplemental Figure 8A). This evidence concerns the gene CHCHD2 and metabolic dysfunction-associated steatohepatitis.